Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05639907 · ClinicalTrials.gov registry record · NA
Miniscrew Stability and Peri-implant Inflammation When Precoated K21 vs Ethanol Control
A NA study of Inflammation Caused by the Placement of a Temporary Anchorage Device, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05639907: Recruiting NA study of Inflammation Caused by the Placement of a Temporary Anchorage Device, sponsored by University of Colorado, Denver.
NCT05639907 is a NA study of Inflammation Caused by the Placement of a Temporary Anchorage Device that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05639907, a NA study of Inflammation Caused by the Placement of a Temporary Anchorage Device, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if coating miniscrews with K21 would increase the success rate of orthodontic miniscrews by reducing adjacent tissue inflammation.
Primary Outcome
The motility of a TAD is evaluated by gentle manipulation with cotton pliers. Clinical failures will be defined as a mobility greater than or equal to 1mm. Clinical success will be defined as maintenance of stability for a period of 8 weeks.
Conditions Studied
Interventions
- DEVICE K21 Cavity cleanser
- DEVICE Ethanol control
Study Locations (1)
Colorado
- University of Colorado School of Dental Medicine - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-11-11 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT05639907 shows while recruiting
NCT05639907 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Inflammation Caused by the Placement of a Temporary Anchorage Device appearing as the primary indexed condition, and to 2 interventions - of which K21 Cavity cleanser is the first listed.
NCT05639907 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05639907 about?
NCT05639907 is a clinical study titled "Miniscrew Stability and Peri-implant Inflammation When Precoated K21 vs Ethanol Control". To determine if coating miniscrews with K21 would increase the success rate of orthodontic miniscrews by reducing adjacent tissue inflammation.
What is the current status of trial NCT05639907?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-11-11. Estimated completion is 2028-06.
What conditions does trial NCT05639907 study?
This clinical trial studies the following conditions: Inflammation Caused by the Placement of a Temporary Anchorage Device.
What interventions are being tested in trial NCT05639907?
The interventions under investigation include: K21 Cavity cleanser (DEVICE), Ethanol control (DEVICE).
Who is sponsoring clinical trial NCT05639907?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05639907 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05639907's enrollment target sits among peer trials
30 1594th of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI